Jane Street Group LLC Sells 1,340,466 Shares of Takeda Pharmaceutical Company Limited (NYSE:TAK)

Jane Street Group LLC lowered its holdings in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK - Free Report) by 91.7% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 121,830 shares of the company's stock after selling 1,340,466 shares during the period. Jane Street Group LLC's holdings in Takeda Pharmaceutical were worth $1,732,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. Catalytic Wealth RIA LLC lifted its stake in shares of Takeda Pharmaceutical by 4.0% in the 2nd quarter. Catalytic Wealth RIA LLC now owns 21,703 shares of the company's stock valued at $281,000 after purchasing an additional 841 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in shares of Takeda Pharmaceutical by 38.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company's stock worth $43,000 after buying an additional 859 shares during the last quarter. Hexagon Capital Partners LLC increased its position in Takeda Pharmaceutical by 34.3% in the third quarter. Hexagon Capital Partners LLC now owns 4,419 shares of the company's stock worth $63,000 after buying an additional 1,129 shares during the last quarter. Gallacher Capital Management LLC lifted its stake in shares of Takeda Pharmaceutical by 7.0% during the 2nd quarter. Gallacher Capital Management LLC now owns 17,365 shares of the company's stock valued at $225,000 after buying an additional 1,136 shares in the last quarter. Finally, Cutter & CO Brokerage Inc. lifted its holdings in Takeda Pharmaceutical by 3.3% during the 2nd quarter. Cutter & CO Brokerage Inc. now owns 41,974 shares of the company's stock worth $543,000 after purchasing an additional 1,347 shares in the last quarter. Institutional investors own 9.17% of the company's stock.

Takeda Pharmaceutical Price Performance

TAK traded down $0.03 on Thursday, reaching $13.14. The company had a trading volume of 2,100,308 shares, compared to its average volume of 1,828,054. Takeda Pharmaceutical Company Limited has a 52-week low of $12.57 and a 52-week high of $15.08. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.77 and a current ratio of 1.28. The company has a market cap of $41.81 billion, a price-to-earnings ratio of 22.66, a P/E/G ratio of 0.25 and a beta of 0.51. The business has a 50 day simple moving average of $13.64 and a 200 day simple moving average of $13.87.

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.